𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neurochemical findings in the MPTP model of Parkinson's disease

✍ Scribed by N. Schmidt; B. Ferger

Publisher
Springer
Year
2001
Tongue
English
Weight
300 KB
Volume
108
Category
Article
ISSN
1435-1463

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Neuroprotective effects of (Β±)-kavain in
Neuroprotective effects of (Β±)-kavain in the MPTP mouse model of Parkinson's disease
✍ Nicole Schmidt; Boris Ferger πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 319 KB πŸ‘ 2 views

This is the first study to investigate the potential protective effects of the lipophilic kavapyrone (+/-)-kavain in the experimental MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) model of Parkinson's disease (PD). Male C57BL/6 mice were treated with (+/-)-kavain (50, 100, or 200 mg/kg i.p.) o

The neurochemical mechanism of rebound p
The neurochemical mechanism of rebound psychosis in Parkinson's disease
✍ Spiridon Papapetropoulos; Deborah C. Mash πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 35 KB πŸ‘ 1 views

## Abstract A reply to this letter has been published in __Movement__ DisordersMov Disord (2005) 20 (4) 515.

Topiramate reduces levodopa-induced dysk
Topiramate reduces levodopa-induced dyskinesia in the MPTP-lesioned marmoset model of Parkinson's disease
✍ Monty A. Silverdale; S.L. Nicholson; A.R. Crossman; J.M. Brotchie πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 87 KB πŸ‘ 1 views

## Abstract Overactive AMPA receptor‐mediated transmission may be involved in the pathogenesis of levodopa‐induced dyskinesia. The mechanism of action of the anticonvulsant drug topiramate involves attenuation of AMPA receptor‐mediated transmission. In this study, the potential antidyskinetic actio